X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (220) 220
male (142) 142
middle aged (140) 140
female (135) 135
adult (118) 118
hematology (107) 107
aged (97) 97
oncology (74) 74
index medicus (47) 47
adolescent (44) 44
transplantation (37) 37
aged, 80 and over (34) 34
treatment outcome (32) 32
therapy (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (30) 30
cancer (25) 25
chemotherapy (24) 24
immunology (22) 22
stem cells (22) 22
medicine, general & internal (19) 19
acute disease (18) 18
antineoplastic agents - therapeutic use (18) 18
care and treatment (18) 18
survival (18) 18
research (17) 17
remission induction (16) 16
transplantation, homologous (16) 16
ferritins - blood (15) 15
leukemia (15) 15
retrospective studies (15) 15
risk factors (15) 15
young adult (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
hematopoietic stem cell transplantation (14) 14
lymphoma (14) 14
prognosis (14) 14
time factors (14) 14
bone-marrow transplantation (13) 13
chronic myelogenous leukemia (13) 13
hematology, oncology and palliative medicine (13) 13
interferon type i - therapeutic use (13) 13
recombinant proteins (13) 13
survival analysis (13) 13
survival rate (13) 13
bone marrow transplantation (12) 12
follow-up studies (12) 12
austria (11) 11
child (11) 11
disease-free survival (11) 11
health aspects (11) 11
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (11) 11
recurrence (11) 11
stem cell transplantation (11) 11
antibodies, monoclonal - therapeutic use (10) 10
bone marrow - pathology (10) 10
cyclophosphamide - administration & dosage (10) 10
disease (10) 10
neoplasm staging (10) 10
rituximab (10) 10
analysis (9) 9
antineoplastic agents - adverse effects (9) 9
antineoplastic combined chemotherapy protocols - administration & dosage (9) 9
bone-marrow-transplantation (9) 9
cells (9) 9
child, preschool (9) 9
clinical trials (9) 9
combined modality therapy (9) 9
cyclophosphamide (9) 9
cytarabine - administration & dosage (9) 9
drug therapy (9) 9
high-dose chemotherapy (9) 9
leukemia, myeloid - genetics (9) 9
leukemia, myeloid - pathology (9) 9
non-hodgkins-lymphoma (9) 9
pregnancy (9) 9
transplantation, autologous (9) 9
animals (8) 8
bone-marrow (8) 8
diagnosis (8) 8
double-blind method (8) 8
hematopoietic stem cell transplantation - methods (8) 8
iron - blood (8) 8
leukemia, myelogenous, chronic, bcr-abl positive - therapy (8) 8
medicine & public health (8) 8
multiple myeloma (8) 8
prospective studies (8) 8
stem-cell transplantation (8) 8
versus-host-disease (8) 8
age factors (7) 7
antineoplastic agents - administration & dosage (7) 7
chronic disease (7) 7
combination (7) 7
dose-response relationship, drug (7) 7
follicular lymphoma (7) 7
further section (7) 7
further sections · weitere sektionen (7) 7
graft vs host disease - prevention & control (7) 7
hematopoietic stem cells (7) 7
hemic and lymphatic diseases (7) 7
leukemia, myelogenous, chronic, bcr-abl positive - pathology (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Mohty, Mohamad and Terpos, Evangelos and Mateos, Maria-Victoria and Cavo, Michele and Lejniece, Sandra and Beksac, Meral and Bekadja, Mohamed Amine and Legiec, Wojciech and Dimopoulos, Meletios and Stankovic, Svetlana and Durán, Maria Soledad and De Stefano, Valerio and Corso, Alessandro and Kochkareva, Yulia and Laane, Edward and Berthou, Christian and Salwender, Hans and Masliak, Zvenyslava and Pečeliūnas, Valdas and Willenbacher, Wolfgang and Silva, João and Louw, Vernon and Nemet, Damir and Borbényi, Zita and Abadi, Uri and Pedersen, Robert Schou and Černelč, Peter and Potamianou, Anna and Couturier, Catherine and Feys, Caroline and Thoret-Bauchet, Florence and Boccadoro, Mario and Bekadja, Mohamed and Hamladji, Rose-Marie and Ali, Hocine Ait and Hamdi, Selma and Touhami, Hadj and Mansour, Nourredine Sidi and Willenbacher, Wolfgang and Linkesch, Werner and Nemet, Damir and Pedersen, Robert Shou and Abildgaard, Niels and Laane, Edward and Hein, Marju and Mohty, Mohamad and Eveillard, Jean Richard and Yamani, Abderrazak el and Moreau, Philippe and Sanhes, Laurence and Lepeu, Gérard and Laribi, Kamel and Jourdan, Eric and Fitoussi, Olivier and Allangba, Olivier and Fleury, Joël and Escoffre, Martine and Benramdane, Riad and Cartron, Guillaume and Dine, Gérard and Legouffe, Eric and Harich, Hanns-Detlev and Illmer, Thomas and Dörfel, Steffen and Hannig, Carla Verena and Koenigsmann, Michael and Prange-Krex, Gabriele and Salwender, Hans and Tamm, Ingo and Zeller, Wolfgang and Maasberg, Michael and Schlag, Rudolf and Klausmann, Martine and Uhlig, Jens and Alkemper, Burkhard and Schütz, Stefan and Tessen, Hans-Werner and Mohr, Benno and Schmidt, Peter and Heinrich, Bernhard and Hebart, Holger and Seipelt, Gernot and Zoeller, Thomas and Heits, Frank and Müller-Naendrup, Clemens and Hansen, Richard and Repp, Roland and Von Weikersthal, Ludwig Fischer and Schmits, Rudolf and Heßling, Jörg and Krammer-Steiner, B and Janzen, Viktor and Schauer, Michael and Grüner, Marcus W and Kisro, Jens and Denzlinger, Claudio and Freier, Werner and Junghanss, Christian and Görner, Martin and Laichinger, Katharina and ... and EMMOS Investigators
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2018, Volume 18, Issue 10, pp. e401 - e419
Multiple myeloma (MM) remains an incurable disease, with little information available on its management in real-world clinical practice. The results of the... 
Stem cell transplantation | Observational study | Bortezomib | Routine practice | Global | UNITED-STATES | SURVIVAL | GUIDELINES | INDUCTION | PLUS DEXAMETHASONE | ONCOLOGY | TREATMENT PATTERNS | THERAPIES | STEM-CELL TRANSPLANTATION | HEMATOLOGY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 17, pp. 1621 - 1634
The addition of the oral proteasome inhibitor ixazomib to a regimen of lenalidomide plus dexamethasone led to a significant prolongation of progression-free... 
SUPERIORITY | MEDICINE, GENERAL & INTERNAL | CARFILZOMIB | RANDOMIZED PHASE-3 | THERAPY | PROTEASOME INHIBITOR MLN9708 | QUALITY-OF-LIFE | BORTEZOMIB | THALIDOMIDE | ANTITUMOR-ACTIVITY | TRANSPLANTATION | Glycine - analogs & derivatives | Glycine - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Boron Compounds - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Exanthema - chemically induced | Aged, 80 and over | Adult | Glycine - administration & dosage | Dexamethasone - administration & dosage | Double-Blind Method | Administration, Oral | Kaplan-Meier Estimate | Proportional Hazards Models | Thrombocytopenia - chemically induced | Thalidomide - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Boron Compounds - adverse effects | Aged | Care and treatment | Dosage and administration | Dexamethasone | Multiple myeloma | Thrombocytopenia | Inhibitor drugs | Drug therapy | Peripheral neuropathy | Survival | Patients | Drug dosages | Proteasome inhibitors | Quality of life | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 9, pp. 855 - 864
Journal Article
Journal Article
Blood, ISSN 0006-4971, 06/2011, Volume 117, Issue 23, pp. 6375 - 6382
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 3, pp. 308 - 313
Purpose We report on a multicenter phase II trial of 90yttrium-ibritumomab-tiuxetan (90YIT) as first-line stand-alone therapy for patients with follicular... 
Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
British Journal of Haematology, ISSN 0007-1048, 2014, Volume 167, Issue 4, pp. 466 - 477
Journal Article
Blood, ISSN 0006-4971, 11/2007, Volume 110, Issue 9, pp. 3374 - 3383
Journal Article